30-Day Notice

46594

Federal Register / Vol. 78, No. 148 / Thursday, August 1, 2013 / Notices

Dated: July 26, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer.
[FR Doc. 2013–18452 Filed 7–31–13; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Start-up
Exclusive License: Topical Antibiotic
With Immune Stimulating
Oligodeoxynucleotide Molecules To
Speed Wound Healing; and Use of CpG
Oligodeoxynucleotides To Induce
Epithelial Cell Growth
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

This is notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Institutes of Health
(NIH), Department of Health and Human
Services, is contemplating the grant of a
start-up exclusive license to practice the
inventions embodied in: US provisional
Applications 61/639,688 (E–294–2011/
0–US–01) filed April 27, 2012 and PCT
application PCT/US2013034639
(E–294–2011/0–PCT–02) filed March 29,
2013, each entitled ‘‘Topical Antibiotic
with Immune Stimulating
oligodeoxynucleotide Molecules to
Speed Wound Healing’’ and US
application 12/205,756 (E–328–2001/1–
US–01) filed September 2008 and issued
as US patent 8,466,116, each entitled
‘‘Use of CpG Oligodeoxynucleotides to
Induce Epithelial Cell Growth’’ to
Tollgene having a place of business at
2429 Ginny Way, Lafayette, CO 80026.
The patent rights in these inventions
have been assigned to the United States
of America.
DATES: Only written comments and/or
application for a license that are
received by the NIH Office of
Technology Transfer on or before
August 16, 2013 will be considered.
ADDRESSES: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Tedd Fenn, Office of Technology
Transfer, National Institutes of Health,
6011 Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; Email:
[email protected]; Telephone:
424–500–2005; Facsimile: 301–402–
0220.
SUPPLEMENTARY INFORMATION: The
prospective start-up exclusive license
will be royalty bearing and will comply

mstockstill on DSK4VPTVN1PROD with NOTICES

SUMMARY:

VerDate Mar<15>2010

17:02 Jul 31, 2013

Jkt 229001

with the terms and conditions of 35
U.S.C. 209 and 37 CFR 404. The
prospective exclusive license may be
granted unless, within fifteen (15) days
from the date of this published Notice,
NIH receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR part 404.
These technologies relate to relate to
use of CpG oligodeoxynucleotides
(ODNs) to accelerate wound healing.
The E–294–2011/0, technology relates to
an antibiotic composition containing the
toll-like receptor-7 (TLR7) ligand
(imidazoquinoline) and an
immunostimulatory K ODN. There is
evidence that this formulation may
produce more rapid wound healing
versus standard antibiotic formulations.
Because standard antibiotics eliminate
bacteria at a wound site, they also
eliminate the molecular signals present
in bacterial DNA that stimulate the
immune system’s wound healing
processes. The ODN and
imidazoquinoline act as artificial
immune stimulants that mimic the
bacterial signals to improve healing
rates. The E–328–2001/1 technology
relates to a method of inducing
epithelial cell growth by administration
of immunostimulatory ODNs. The
stimulation of epithelial cell growth also
promotes wound healing.
The proposed field of exclusivity may
be limited to human and veterinary
therapeutics for treatment of wounds.
Properly filed competing applications
for a license filed in response to this
notice will be treated as objections to
the contemplated license. Comments
and objections submitted in response to
this notice will not be made available
for public inspection, and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: July 26, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2013–18449 Filed 7–31–13; 8:45 am]
BILLING CODE 4140–01–P

PO 00000

DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
Extension of Agency Information
Collection Activity Under OMB Review:
Aviation Security Customer
Satisfaction Performance
Measurement Passenger Survey
Transportation Security
Administration, DHS.
ACTION: 30-day notice.
AGENCY:

This notice announces that
the Transportation Security
Administration (TSA) has forwarded the
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0013,
abstracted below to OMB for review and
approval of an extension of the
currently approved collection under the
Paperwork Reduction Act (PRA). The
ICR describes the nature of the
information collection and its expected
burden. TSA published a Federal
Register notice, with a 60-day comment
period soliciting comments, of the
following collection of information on
May 30, 2013, 78 FR 32416. The
collection involves surveying travelers
to measure customer satisfaction of
aviation security in an effort to more
efficiently manage its security screening
performance at airports.
DATES: Send your comments by
September 3, 2013. A comment to OMB
is most effective if OMB receives it
within 30 days of publication.
ADDRESSES: Interested persons are
invited to submit written comments on
the proposed information collection to
the Office of Information and Regulatory
Affairs, OMB. Comments should be
addressed to Desk Officer, Department
of Homeland Security/TSA, and sent via
electronic mail to
[email protected] or faxed
to (202) 395–6974.
FOR FURTHER INFORMATION CONTACT:
Susan L. Perkins, TSA PRA Officer,
Office of Information Technology (OIT),
TSA–11, Transportation Security
Administration, 601 South 12th Street,
Arlington, VA 20598–6011; telephone
(571) 227–3398; email
[email protected].
SUPPLEMENTARY INFORMATION:
SUMMARY:

Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation is

Frm 00030

Fmt 4703

Sfmt 4703

E:\FR\FM\01AUN1.SGM

01AUN1

Federal Register / Vol. 78, No. 148 / Thursday, August 1, 2013 / Notices
available at http://www.reginfo.gov.
Therefore, in preparation for OMB
review and approval of the following
information collection, TSA is soliciting
comments to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.

mstockstill on DSK4VPTVN1PROD with NOTICES

Information Collection Requirement
Title: Aviation Security Customer
Satisfaction Performance Measurement
Passenger Survey.
Type of Request: Extension of a
currently approved collection.
OMB Control Number: 1652–0013.
Forms(s): Survey.
Affected Public: Travelling public.
Abstract: OMB Control Number 1652–
0013; Aviation Security Customer
Satisfaction Performance Measurement
Passenger Survey. TSA, with OMB’s
approval, has conducted surveys of
passengers and now seeks approval to
continue this effort. TSA plans to
conduct passenger surveys at airports
nationwide. The surveys will be
administered using an intercept
methodology. The intercept
methodology uses TSA personnel who
are not in uniform to hand deliver paper
survey forms to passengers immediately
following the passenger’s experience
with TSA’s checkpoint security
functions. Passengers are invited,
though not required, to complete and
return the survey using either an online
portal or by responding in writing to the
survey questions on the customer
satisfaction card and depositing the card
in a drop-box at the airport or using U.S.
mail; TSA personnel decide the method
by which passengers will be asked to
complete and return the survey. TSA
uses the intercept methodology to
randomly select passengers to complete
the survey in an effort to gain survey
data representative of all passenger
demographics, including passengers
who—
• Travel on weekdays or weekends;
• Travel in the morning, mid-day, or
evening;

VerDate Mar<15>2010

17:02 Jul 31, 2013

Jkt 229001

• Pass through each of the different
security screening locations in the
airport;
• Are subject to more intensive
screening of their baggage or person;
and
• Experience different volume
conditions and wait times as they
proceed through the security
checkpoints.
The survey includes 10 to 15
questions. Each question promotes a
quality response so that TSA can
identify areas in need of improvement.
All questions concern aspects of the
passenger’s security screening
experience.
TSA intends to collect this
information in order to continue to
assess customer satisfaction in an effort
to more efficiently manage its security
screening performance at airports. In its
future surveys, TSA wishes to obtain
more detailed, airport-specific data that
TSA can use to enhance customer
experiences and its performance at
specific airports. In order to gain more
detailed information regarding customer
experiences, TSA is submitting 84
questions to OMB for approval. Eightyone questions have been previously
approved by OMB and three questions
are being submitted to OMB for the first
time. The new questions will allow TSA
to better measure customer satisfaction
with Risk-Based Security, an effort to
focus TSA resources and improve the
passenger experience at security
checkpoints by applying new
intelligence-driven, risk-based screening
procedures and enhancing the use of
technology. Since there are some
passengers who present a low level of
risk, Risk-Based Security allows TSA to
focus resources on higher-risk or
unknown travelers, thereby increasing
the level of security. Each survey
question seeks to gain information
regarding one of the following
categories:
• Confidence in Personnel
• Confidence in Screening Equipment
• Confidence in Security Procedures
• Convenience of Divesting
• Experience at Checkpoint
• Satisfaction with Wait Time
• Separation from Belongings
• Separation from Others in Party
• Stress Level
TSA personnel use random procedures
to select passengers to voluntarily
participate in the survey until TSA
obtains the desired sample size. The
samples may be selected with one
randomly selected time and location or
span multiple times and locations.
Designated TSA personnel at each
airport may choose one or more of the

PO 00000

Frm 00031

Fmt 4703

Sfmt 4703

46595

following sample methods when
planning the survey, which include a
business card that directs customers to
an online portal, a customer satisfaction
card with survey questions on the card,
or a customer satisfaction card with
survey questions on the card and a link
to the online portal. All responses are
voluntary and there is no burden on
passengers who choose not to respond.
Number of Respondents: 25,000.
Estimated Annual Burden Hours: An
estimated 2083.3 hours annually.
Dated: July 26, 2013.
Susan L. Perkins,
TSA Paperwork Reduction Act Officer, Office
of Information Technology.
[FR Doc. 2013–18483 Filed 7–31–13; 8:45 am]
BILLING CODE9110–05–P

DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation of SGS North America,
Inc., as a Commercial Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation of SGS
North America, Inc., as a commercial
laboratory.
AGENCY:

Notice is hereby given,
pursuant to CBP regulations, that SGS
North America, Inc., has been
accredited to test petroleum, petroleum
products, organic chemicals and
vegetable oils for customs purposes for
the next three years as of April 19, 2013.
DATES: Effective Dates: The
accreditation of SGS North America,
Inc., as commercial laboratory became
effective on April 19, 2013. The next
triennial inspection date will be
scheduled for April 2016.
FOR FURTHER INFORMATION CONTACT:
Approved Gauger and Accredited
Laboratories Manager, Laboratories and
Scientific Services, U.S. Customs and
Border Protection, 1300 Pennsylvania
Avenue NW., Suite 1500N, Washington,
DC 20229, tel. 202–344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.12,
that SGS North America, Inc., 101
Corporate Pl, Vallejo, CA 94590, has
been accredited to test petroleum,
petroleum products, organic chemicals
and vegetable oils for customs purposes,
in accordance with the provisions of 19
CFR 151.12. Anyone wishing to employ
this entity to conduct laboratory
analyses should request and receive
written assurances from the entity that
SUMMARY:

E:\FR\FM\01AUN1.SGM

01AUN1